Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

Amazon.com logo

Merrill Lynch’s 4 Red-Hot Stocks to Buy With Up to 75% Upside Potential

When a market has stayed in bull market form for almost eight years, momentum investors and traders start to ask themselves, where do I look for alpha now? The question, as ...
Read Full Story »
Good heart health

Friday’s 6 Biopharma Movers That Can’t Be Ignored

There is a very positive sentiment in the health care sector considering the new Trump administration that will be taking over in just two weeks. The health care sector was ...
Read Full Story »
thumbs up and down

Key Analyst Upgrades and Downgrades for Tuesday: Alcoa, Arch Coal, Baidu, Ciena, JD.com, Vale and Many More

Stocks were indicated higher on Tuesday, with the Dow Jones Industrial Average still 50 points shy of DJIA 20,000 right after the opening bell. Stocks are challenging last week's all-time ...
Read Full Story »
2017

Merrill Lynch Out With 11 Top Stock Ideas for 2017

The clock is ticking on 2016, and what a year it’s been. With the S&P 500 looking like it may be a double-digit winner, as it is currently up over ...
Read Full Story »
upside

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
automatic inspection machine

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter financial results before the markets opened on Friday. The company posted $3.13 in earnings per share (EPS) on $1.22 billion in revenue. ...
Read Full Story »
blue eye

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

Ocular Therapeutix Inc. (NASDAQ: OCUL) shares jumped early on Thursday after a new partnership was announced with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Specifically, these companies will collaborate on the development ...
Read Full Story »
Test tubes

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

We have talked in detail about how the political rhetoric has weighed upon the biotech industry. Toss in some scrutiny of pricing over a widely used product, and you have ...
Read Full Story »
graph

8 Top Movers and Hot Stocks for Monday

Stocks overall were fractionally higher early on Monday, August 29, 2016. That makes the big percentages gainers and losers and the companies with big headline news stand out even more than ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

Stocks were indicated to open higher on Friday after an unexpectedly stronger than expected payrolls report. Investors are looking for ways to make money, and they have proven over and ...
Read Full Story »
money

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

The Nasdaq Biotechnology Index has underperformed the broader market for some time. This year the index is still down about 13%, versus the 6% rise for the S&P 500. We ...
Read Full Story »
Stock Price

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

June 22, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Wednesday's session. NYSE decliners led advancers by 5 to 4 ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

Stocks were indicated higher yet again on Wednesday, with the Dow over 18,000 and the S&P 500 back at 2,100. The memories of all the selling pressure during the first ...
Read Full Story »
clinical trials

Regeneron Rises on Positive Top-Line Results

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), in conjunction with Sanofi, released top-line results for its most recent late-stage study. The companies announced that two placebo-controlled Phase 3 studies evaluating investigational dupilumab ...
Read Full Story »
Pills and tablets

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen Inc. (NASDAQ: AMGN) on a cholesterol drug patent. However, Regeneron ...
Read Full Story »